Mast cells, peptides and cardioprotection - An unlikely marriage?

Autonomic and Autacoid Pharmacology

Volumn 29, Issue 3, 2009, Pages 73-84

  Walsh, S K ^a   Kane, K A ^b   Wainwright, C L ^c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

Adrenomedullin; Atrial natriuretic peptide; Cardioprotection; Endothelin; Mast cells; Myocardial ischaemia; Relaxin

Indexed keywords

ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; CROMOGLYCATE DISODIUM; CYTOKINE; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; HISTAMINE; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RELAXIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARRHYTHMOGENESIS; BLOOD PRESSURE; BLOOD VESSEL TONE; CARDIOVASCULAR SYSTEM; CONCENTRATION RESPONSE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; REPERFUSION INJURY; REVIEW; VASOCONSTRICTION;

ANIMALS; CARDIOTONIC AGENTS; CELL DEGRANULATION; HEART DISEASES; HUMANS; MAST CELLS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEUROPEPTIDES;

EID: 67651068261     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2009.00436.x     Document Type: Review

References (145)

1. ADT, M., PATELLA, V., MARINO, I. et al. (1994). Immunologic characterization of human heart mast cells. J. Invest. Dermatol., 103, 621.
2. AKAGI, M., HAMADA, K., NISHIOKA, E. et al. (1995). Role of histamine H3 receptor on hypoxia-reoxygenation-induced cardiac dysfunction in guinea pigs. Methods Find. Exp. Clin. Pharmacol., 17, 30 35. (Pubitemid 26022889)
3. ANDRADE, M.V.M., HIRAGUN, T. BEAVEN, M.A. (2004). Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells. J. Immunol., 172, 7254 7262. (Pubitemid 38747584)
4. ASSEM, E.S. GHANEM, N.S. (1988). Demonstration of IgE-sensitized mast cells in human heart and kidney. Int. Arch. Allergy Immunol., 87, 101 104. (Pubitemid 18239566)
5. ASSEM, E.S., MACHADO, F.R. GHANEM, N.S. (1986). Cardiac mast cells: partial purification of guinea-pig atrial mast cells and release from them of histamine and leukotriene C4 by immune and non-immune stimuli. Agents. Actions, 18, 167 171. (Pubitemid 16113247)
6. BALTOGIANNIS, G.G., TSALIKAKIS, D.G., MITSI, A.C. et al. (2005). Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats. Cardiovasc. Res., 67, 647 654. (Pubitemid 41033360)
7. BANI, G., BANI-SACCHI, T., BIGAZZI, M. BIANCHI, S. (1988). Effects of relaxin on the microvasculature of mouse mammary gland. Histol. Histopathol., 3, 337 343. (Pubitemid 18271448)
8. BANI, D., BIGAZZI, M., MASINI, E. et al. (1995). Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets. Lab. Invest., 73, 709 716.
9. BANI, T., BALLATI, L., MASINI, E. et al. (1997). Relaxin counteracts asthma-like reaction induced by inhaled antigen in sensitized guinea pigs. Endocriology, 138, 1909 1915. (Pubitemid 27180806)
10. BANI, D., MASINI, E., BELLO, M.G. et al. (1998). Relaxin protects against myocardial injury caused by ischemia and reperfusion in the rat heart. Am. J. Pathol., 152, 1367 1376. (Pubitemid 28221889)
11. BANI-SACCHI, T., BIGAZZI, M., BANI, D. et al. (1995). Relaxin-induced increased coronary flow through stimulation of nitric oxide production. Br. J. Pharmacol., 116, 1589 1594.
12. BELLONI, A.S., GUIDOLIN, D., SALMASO, R. et al. (2005). Adrenomedullin, ANP and BNP are colocalized in a subset of endocrine cells in the rat heart. Int. J. Mol. Med., 15, 567 571.
13. BELLONI, A.S., PETRELLI, L., GUIDOLIN, D. et al. (2006). Identification and localization of adrenomedullin-storing cardiac mast cells. Int. J. Mol. Med., 17, 709 713.
14. BELTOWSKI, J. JAMROZ, A. (2004). Adrenomedullin-what do we know 10 years since its discovery? Pol. J. Pharmacol., 56, 5 27. (Pubitemid 38515282)
15. BHATTACHARYA, K., FARWELL, K., HUANG, M. et al. (2007). Mast cell deficient W-Wv mice have lower serum IL-6 and less cardiac tissue necrosis than their normal littermates following myocardial ischemia/reperfusion. Int. J. Immunopathol. Pharmacol., 20, 69 74. (Pubitemid 46506877)
16. BOROS, M., KASAZAKI, J., ORDOGH, B. NAGY, S. (1999). Mast cell degranulation prior to ischemia decreases intestinal-reperfusion injury in the canine small intestine. Inflamm. Res., 48, 193 198. (Pubitemid 29192521)
17. A receptors. Clin. Sci., 103, 31 34.
18. i-like proteins, a receptor-independent effect of kinins in mast cells. Mol. Pharmacol., 38, 816 822.
19. ATP channels in the isolated rat heart. Cardiovasc. Res., 32, 920 929. (Pubitemid 26342657)
20. CAMERON, J.S., GAIDE, M.S., GOAD, P.L. et al. (1985). Enhanced adverse electrophysiologic effects of histamine after myocardial infarction in guinea pigs. J. Pharmacol. Exp. Ther., 232, 480 484. (Pubitemid 15162910)
21. CHAI, O.H., LEE, Y.H., HAN, E.H. et al. (2000). Atrial natriuretic peptide induces rat peritoneal mast cell activation by cGMP-independent and calcium uptake dependent mechanism. Exp. Mol. Med., 32, 179 186. (Pubitemid 32041696)
22. CHANCEY, A.L., BROWER, G.L. JANICKI, J.S. (2002). Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function. Am. J. Physiol. Heart. Circ. Physiol., 282, 2152 2158.
23. CHEN, B.N., RAYNER, T.E., MENADUE, M.F. et al. (1993). Effect of ischaemia and role of eicosanoids in release of atrial natriuretic factor from rat heart. Cardiovasc. Res., 27, 1576 1579. (Pubitemid 23297520)
24. CHURCH, M.K., EL-LATI, S. CAULFIELD, J.P. (1991). Neuropeptide-induced secretion from human skin mast cells. Int. Arch. Allergy. Appl. Immunol., 94, 310 318.
25. COULSON, C.C., THORP, J.M.J.R., MAYER, D.C. CEFALO, R.C. (1996). Central hemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model. Obstet. Gynecol., 87, 620 622.
26. CROCKETT, T.R., SHARIF, I., KANE, K.A. WAINWRIGHT, C.L. (2000). Sarafotoxin 6c protects against ischaemia-induced cardiac arrhythmias in vivo and in vitro in the rat. J. Cardiovasc. Pharmacol., 36, 297 299.
27. CROCKETT, T.R., SCOTT, G.A., MCGOWAN, N.W.A. et al. (2001). Anti-arrhythmic and electrophysiological effects of the endothelin receptor antagonists, BQ-123 and PD161721. Eur. J. Pharmacol., 432, 71 77. (Pubitemid 33153135)
28. DAI, S. OGLE, C.W. (1990). Ventricular histamine concentrations and mast cell counts in the rat heart during acute ischaemia. Agents. Actions, 29, 138 143. (Pubitemid 20098436)
29. DAVANI, S., MURET, P., ROYER, B. et al. (2002). Ischaemic preconditioning and mast cell histamine release: microdialysis of isolated rat hearts. Pharmacol. Res., 45, 383 390. (Pubitemid 35304504)
30. DE PLATER, G.M., MARTIN, R.L. MILBURN, P.J. (1998). The natriuretic peptide (OVCNP-39) from platypus (Ornithorhynchus Anatinus) venom relaxes the isolated rat uterus and promotes oedema and mast cell histamine release. Toxicon, 36, 847 857. (Pubitemid 28267067)
31. DI BELLO, M.G., GAMBASSI, F., MUGNAI, L. et al. (1995). Relaxin enhances the coronary outflow in perfused guinea-pig heart: Correlation with histamine and nitric oxide. Inflamm. Res., 44, 102 103.
32. DSCHIETZIG, T., RICHTER, C. BARTSCH, C. (2001). The pregnancy hormone relaxin is a player in human heart failure. FASEB J., 15, 2187 2195. (Pubitemid 32927936)
33. EHRENREICH, H., BURD, P.R., ROTTEM, M. et al. (1992). Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. New. Biol., 4, 147 156.
34. ERCAN, Z.S., ILHAN, M., KILINC, M. TURKER, R.K. (1996). Arrhythmogenic action of endothelin peptides in isolated perfused whole hearts from guinea pigs and rats. Pharmacology, 53, 234 240. (Pubitemid 26390325)
35. ERJAVEC, F. (1982). Species and tissue differences of histamine storage and release. Agents. Actions, 12, 81 85. (Pubitemid 12076386)
36. ESTENSEN, R.D. (1984). Eosinophilic myocarditis: a role for mast cells? Arch. Pathol. Lab. Med., 108, 358 359.
37. FERRY, X., BREHIN, S., KAMIL, R. LANDRY, Y. (2002). G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides, 23, 1507 1515. (Pubitemid 35223021)
38. γ in mast cells. J. Immunol., 167, 4805 4813. (Pubitemid 33009707)
39. FINKEL, M.S., HOFFMAN, R.A., SHEN, L. et al. (1993). Interleukin-6 (IL-6) as a mediator of stunned myocardium. Am. J. Cardiol., 71, 1231 1232. (Pubitemid 23137577)
40. FOREMAN, J.C. MONGAR, J.L. (1972). The role of alkaline earth ions in anaphylactic histamine secretion. J. Physiol., 244, 753 769.
41. FORMAN, M.F., BROWER, G.L. JANICKI, J.S. (2004). Spontaneous histamine secretion during isolation of rat cardiac mast cells. Inflamm. Res., 53, 453 457. (Pubitemid 39382167)
42. FRANGOGIANNIS, N.G., SMITH, C.W. ENTMAN, M.L. (2002). The inflammatory response in myocardial infarction. Cardiovasc. Res., 53, 31 47. (Pubitemid 34020764)
43. FUDER, H., RIES, P. SCHWARZ, P. (1994). Histamine and serotonin released from the rat perfused heart by compound 48-80 or by allergen challenge influence noradrenaline or acetylcholine exocytotic release. Fundam. Clin. Pharmacol., 8, 477 490.
44. A-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats. J. Cardiovasc. Pharmacol., 25, 634 642.
45. GIANNELLA, E., MASINI, E., PALMERANI, B. et al. (1988). Modulation of anaphylactic histamine release by calcium channel agonists and antagonists. Agents. Actions, 23, 185 187. (Pubitemid 18138867)
46. GILLES, S., ZAHLER, S., WELSCH, U. et al. (2003). Release of TNF-α during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc. Res., 60, 608 616. (Pubitemid 37501118)
47. GOMES, J.C., GREGORIO, E.A. ANTONIO, A. (1984). Granular dissolution of mast cells and histamine release by compound 48/80 in the isolated guinea-pig heart. J. Submicrosc. Cytol., 16, 659 664. (Pubitemid 14016068)
48. GRISTWOOD, R.W., LINCOLN, J.C., OWEN, D.A. SMITH, I.R. (1981). Histamine release from human right atrium. Br. J. Pharmacol., 74, 7 9. (Pubitemid 12196850)
49. HAMID, S.A. BAXTER, G.F. (2005). Adrenomedullin limits reperfusion injury in experimental myocardial infarction. Basic Res. Cardiol., 100, 387 396. (Pubitemid 41300493)
50. HAMID, S.A. BAXTER, G.F. (2006). A critical cytoprotective role of endogenous adrenomedullin in acute myocardial infarction. J. Mol. Cell. Cardiol., 41, 360 363. (Pubitemid 44080224)
51. HELLSTROM, B. HOLMGREN, H. (1950). Numerical distribution of mast cells in the human skin and heart. Acta. Anat (Basel), 10, 81 107.
52. HUMPHREYS, R.A., KANE, K.A. PARRATT, J.A. (1998). Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats. J. Cardiovasc. Pharmacol., 31, 418 423. (Pubitemid 28103622)
53. ITO, B.R., ENGLER, R.L. DEL BALZO, U. (1993). Role of cardiac mast cells in complement C5a-induced myocardial ischemia. Am. J. Physiol. Heart. Circ. Physiol., 264, 1346 1354.
54. JAGGI, A.S., SINGH, M., SHARMA, A. et al. (2007). Cardioprotective effects of mast cell modulators in ischemia/reperfusion-induced injury in rats. Methods Find. Exp. Clin. Pharmacol., 29, 593 600. (Pubitemid 351183139)
55. JOLLY, S.R., ABRAMS, G.D., ROMSON, J.L. et al. (1982). Effects of lodoxamide on ischemic reperfused myocardium. J. Cardiovasc. Pharmacol., 4, 441 448.
56. KAKOURIS, H., EDDIE, L.W. SUMMERS, R.J. (1992). Cardiac effects of relaxin in rats. Lancet, 339, 1076 1078.
57. KASAMA, S., FURUYA, M., TOYAMA, T. et al. (2008). Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Eur. Heart J., 29, 1485 1494. (Pubitemid 351890353)
58. KASZAKI, J., CZOBEL, M., SZALAY, L. et al. (2008). Endothelin-1 induces organ-specific histamine liberation granulocyte accumulation in the rat. Inflamm. Res., 57, 396 402.
59. KATO, K., YIN, H., AGATA, J. et al. (2003). Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am. J. Physiol. Heart. Circ. Physiol., 285, 1506 1514.
60. KATO, T., MURASKI, J., CHEN, Y. et al. (2005). Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J. Clin. Invest., 115, 2716 2730. (Pubitemid 41434399)
61. KELLER, A.M., CLANCY, R.M., BARR, M.L. et al. (1988). Acute reoxygenation injury in the isolated rat heart: role of resident cardiac mast cells. Circ. Res., 63, 1044 1052. (Pubitemid 19004259)
62. KELLEY, J.L., CHI, D.S., ABOU-AUDA, W. et al. (2000). The molecular role of mast cells in atherosclerotic cardiovascular disease. Mol. Med. Today, 6, 304 308. (Pubitemid 30619337)
63. KENNEDY, R.H., HAUER-JENSEN, M. JOSEPH, J. (2005). Cardiac function in hearts isolated from a rat model deficient in mast cells. Am. J. Physiol. Heart. Circ. Physiol., 288, 632 637.
64. KITAKAZE, M., ASAKURA, M., KIM, J. et al. (2007). Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet, 370, 1483 1493. (Pubitemid 47625560)
65. KOMPA, A.R., SAMUEL, C.S. SUMMERS, R.J. (2002). Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): effect of pertussis toxin. Br. J. Pharmacol., 137, 710 718. (Pubitemid 35333097)
66. KRYLOVA, M.I. (2006). Immunocytochemical localization of atrial natriuretic peptide in mast cells of adult brown frog Rana temporaria. Dokl. Biol. Sci., 406, 79 81.
67. LAI, C.P., EGASHIRA, K., TASHIRO, H. et al. (1993). Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris. Circulation, 87, 144 151. (Pubitemid 23019344)
68. LEVI, R. (1972). Effects of exogenous and immunologically released histamine on the isolated heart: A quantitative comparison. J. Pharmacol. Exp. Ther., 182, 227 238.
69. LIN, L. YUAN, W.J. (2002). Involvement of endothelin-1 in acute ischaemic arrythmias in cats and rats. Clin. Sci., 103, 228 232.
70. LINZ, W., SCHOLKENS, B.A., ALBUS, U. et al. (1988). Atrial natriuretic factor protects the isolated working ischaemic rat heart against the action of angiotensin II. J. Hypertens. Suppl., 6, 339 341.
71. LOOI, Y.H., KANE, K.A., MCPHADEN, A.R. WAINWRIGHT, C.L. (2006). Adrenomedullin acts via nitric oxide and peroxynitrite to protect against myocardial ischemia-induced arrhythmias in anaesthetized rats. Br. J. Pharmacol., 148, 599 609. (Pubitemid 43996779)
72. MACKINS, C.J., KANO, S., SEVEDI, N. et al. (2006). Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J. Clin. Invest., 116, 1063 1070.
73. MARONE, G., DE CRESCENZO, G., ADT, M. et al. (1995). Immunological characterization and functional importance of human heart mast cells. Immunopharmacology., 31, 1 18.
74. MARONE, G., BOVA, M., DETORAKI, A. et al. (2004). The human heart as a shock organ in anaphylaxis. Novartis Found. Symp., 257, 133 149.
75. MARTIN, T.R., GALLI, S.J., KATONA, I.M. DRAZEN, J.M. (1989). Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J. Clin. Invest., 83, 1375 1383. (Pubitemid 19113055)
76. MARTYNOVA, M.G., BYSTROVA, O.A., MOISEEVA, O.M. et al. (2005). The presence of ANP in rat peritoneal mast cells. Cell Res., 15, 811 816. (Pubitemid 41653918)
77. MASINI, E., BIANCHI, S., GAMBASSI, F. et al. (1990). Ischemia reperfusion injury and histamine release in isolated and perfused guinea-pig heart: pharmacological interventions. Agents. Actions, 30, 198 201. (Pubitemid 20142279)
78. MASINI, E., BANI, D., BIGAZZI, M. et al. (1994). Effects of relaxin on mast cells. In vitro and in vivo studies in rats and guinea pigs. Clin. Invest., 94, 1974 1980.
79. MASINI, E., DI BELLO, M.G., BANI, D. et al. (1995). Relaxin inhibits histamine release from mat cells: Involvement of nitric oxide production. Inflamm. Res., 44, 12 13.
80. MASINI, E., BANI, D., BELLO, M.G. et al. (1997). Relaxin counteracts myocardial damage induced by ischemia/reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide. Endocrinology, 138, 4713 4720. (Pubitemid 27460907)
81. MASINI, E., BANI, D., SARDI, R. et al. (2000). Dual role of nitric oxide in myocardial ischemia/reperfusion. Inflamm. Res., 49, 78 79.
82. MASINI, E., ZAGLI, G., NDISANG, J.F. et al. (2002). Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway. Br. J. Pharmacol., 137, 337 344.
83. MATSUMURA, T., KUGIYAMA, K., SUGIYAMA, S. et al. (1996). Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophil-induced endothelial cytotoxity. J. Clin. Invest., 97, 2192 2203. (Pubitemid 26167239)
84. MATSUSHIMA, H., YAMADA, N., MATSUE, H. SHIMADA, S. (2004). The effects of endothelin-1 on degranulation, cytokine, and growth factor production by skin-derived mast cells. Eur. J. Pharmacol., 34, 1910 1919. (Pubitemid 39268779)
85. MAURER, M., WEDEMEYER, J., METZ, M. et al. (2004). Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature, 432, 512 516. (Pubitemid 39576533)
86. METCALFE, D.D., BARAM, D. MEKORI, Y.A. (1997). Mast cells. Physiol. Rev., 77, 1033 1079. (Pubitemid 27459579)
87. METZ, M., LAMMEL, V., GIBBS, B.F. MAURER, M. (2006). Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells. Am. J. Pathol., 169, 815 822. (Pubitemid 44411949)
88. MONTRUCCHIO, G., ALLOATTI, G. CAMUSSI, G. (2000). Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev., 80, 1669 1699. (Pubitemid 30764165)
89. MOUSLI, M., BRONNER, C., BUEB, J.L. et al. (1989). Activation of rat peritoneal mast cells by substance P and mastoparan. J. Pharmacol. Exp. Ther., 250, 329 335. (Pubitemid 19195009)
90. MTAIRAG, E.M., HOUARD, X., RAIS, S. et al. (2002). Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions. Arterioscler. Thromb. Vasc. Biol., 22, 1824 1831. (Pubitemid 35315768)
91. MURRAY, D.B., GARDNER, J.D., BROWER, G.L. JANICKI, J.S. (2004). Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation and myocardial remodelling in rats. Am. J. Physiol. Heart Circ. Physiol., 287, 2295 2299.
92. MURRAY, D.B., GARDNER, J.D., LEVICK, S.P. et al. (2007). Response of cardiac mast cells to atrial natriuretic peptide. Am. J. Physiol. Heart. Circ. Physiol., 293, 1216 1222.
93. NAGAYA, N., NISHIKIMI, T., YOSHIHARA, F. et al. (2000). Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 278, 1019 1026.
94. NAKAMURA, R., KATO, J., KITAMURA, K. et al. (2002). Beneficial effects of adrenomedullin on left ventricular remodelling after myocardial infarction in rats. Cardiovasc. Res., 56, 373 380. (Pubitemid 35351559)
95. Ca channels. Cardiovasc. Res., 77, 398 405. (Pubitemid 351197650)
96. NISTRI, S., CHIAPPINI, L., SASSOLI, C. BANI, D. (2003). Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide mediated mechanism. FASEB J., 17, 2109 2111.
97. NISTRI, S., CINCI, L., PERNA, A. et al. (2008). Relaxin induces mast cell inhibition and reduces ventricular arrhythmias in a swine model of acute myocardial infarction. Pharmacol. Res., 57, 43 48.
98. OKAWA, H., HORIMOTO, H., MIENO, S. et al. (2003). Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts. Mol. Cell. Biochem., 248, 171 177. (Pubitemid 36833656)
99. OKUMURA, H., NAGAYA, N. KANGAWA, K. (2003). Adrenomedullin infusion during ischemia/reperfusion attenuates left ventricular remodelling and attenuates myocardial fibrosis in rats. Hypertens. Res., 26, 99 104.
100. OKUMURA, H., NAGAYA, N., ITOH, T. et al. (2004). Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase-Akt-dependent pathway. Circulation, 109, 242 248. (Pubitemid 38114146)
101. OPGENORTH, T.J., BUDZIK, G.P., MOLLISON, K.W. et al. (1990). Atrial peptides induce mast cell histamine release. Peptides, 11, 1003 1007. (Pubitemid 20337199)
102. PARIKH, V. SINGH, M. (1997). Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart. J. Cardiovasc. Pharmacol., 30, 149 156. (Pubitemid 27524513)
103. PARIKH, V. SINGH, M. (1998). Cardiac mast cell stabilization and cardioprotective effect of ischemic preconditioning in isolated rat heart. J. Cardiovasc. Pharmacol., 31, 779 785. (Pubitemid 28217600)
104. PARIKH, V. SINGH, M. (1999). Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection. Pharmacol. Res., 40, 129 137. (Pubitemid 29378092)
105. PATELLA, V., MARINO, I., ARBUSTINI, E. et al. (1995). Human heat mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J. Immunol., 154, 2855 2865.
106. PATELLA, V., MARINO, I., ARBUSTINI, E. et al. (1998). Stem cell factor in mast cells and increased mast cell density in idiopathic and ischaemic cardiomyopathy. Circulation, 97, 971 978. (Pubitemid 28125469)
107. PERNA, A.M., MASINI, E., NISTRI, S. et al. (2005). Human recombinant relaxin reduces heart injury and improves ventricular performance in a swine model of acute myocardial infarction. Ann. N Y Acad. Sci., 1041, 431 433. (Pubitemid 41132281)
108. POUCHLEV, A., YOUROUKOVA, Z. KIPROV, D. (1966). A study of changes in the number of mast cells in the human arterial wall during the stages of development of atherosclerosis. J. Atheroscler. Res., 6, 342 351.
109. RASCHACK, M., JUCHELKA, F. ROZEK-SCHAEFER, G. (1998). The endothelin-A antagonist LU 135 252 supresses ischemic ventricular extrasystoles and fibrillation in pigs and prevents hypoxic cellular decoupling. J. Cardiovasc. Pharmacol., 31, 145 148.
110. RASTEGAR, M.A., VEGH, A., PAPP, J.G. PARRATT, J.R. (2000). Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogs. Cardiovasc. Drugs Ther., 14, 471 479. (Pubitemid 30802880)
111. RORK, T.H., WALLACE, K.L., KENNEDY, D.P. et al. (2008). Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation. Am. J. Physiol. Heart. Circ. Physiol., 295, 1825 1833.
112. SAITO, H.F., OKAJIMA, T.F.P., MOLSKI, R.I. et al. (1987). Effects of ADP-ribosylation of GTP-binding protein by pertussis-toxin on immunoglobulin E-dependent and independent histamine release from mast cells and basophils. J. Immunol., 138, 3927 3934.
113. SANGAWA, K., NAKANISHI, K., ISHINO, K. et al. (2004). Atrial natriuretic peptide protects against ischemia/reperfusion injury in the isolated rat heart. Ann. Thorac. Surg., 77, 233 237. (Pubitemid 38130016)
114. SANTONE, D.J., SHAHANI, R., RUBIN, B.B. et al. (2008). Mast cell stabilization improves cardiac contractile function following hemorrhagic shock and resuscitation. Am. J. Physiol. Heart. Circ. Physiol., 294, 2456 2464.
115. SCHNEIDER, L.A., SCHLENNER, S.M., FEYERABEND, T.B. et al. (2007). Molecular mechanism of mast cell-mediated innate defence against endothelin and snake venom sarafotoxin. J. Exp. Med., 204, 2629 2639. (Pubitemid 350044788)
116. SEZAI, A., HATA, M., WAKUI, S. et al. (2007). Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. Circ. J., 71, 1401 1407. (Pubitemid 47381271)
117. SHARIF, I., KANE, K.A. WAINWRIGHT, C.L. (1998). Endothelin and ischaemic arrhythmias - antiarrhythmic or arrhythmogenic? Cardiovasc. Res., 39, 625 632. (Pubitemid 28407595)
118. SILVER, R.B., REID, A.C., MACKINS, C.J. et al. (2004). Mast cells: a unique source of renin. Proc. Natl Acad. Sci. USA, 101, 13607 13612. (Pubitemid 39238450)
119. SINGH, M. SAINI, H.K. (2003). Resident cardiac mast cells and ischemia/reperfusion injury. J. Cardiovasc. Pharmacol. Ther., 8, 135 148. (Pubitemid 36701938)
120. SPERR, W.R., CZERWENKA, K., MUNDIGLER, G. et al. (1993). Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells. Int. Arch. Allergy Immunol., 102, 170 175. (Pubitemid 23285373)
121. SPERR, W.R., BANKL, H.C., MUNDIGLER, G. et al. (1994). The human cardiac mast cell: localization, isolation, phenotype and functional characterization. Blood, 84, 3876 3884. (Pubitemid 24362488)
122. STAHL, G.L., TERASHITA, G. LEFER, A.M. (1988). Role of platelet-activating factor in propagation of cardiac damage during myocardial ischemia. J. Pharmacol. Exp. Ther., 244, 898 904. (Pubitemid 18090103)
123. STANGL, V., BAUMANN, G., STANGL, K. FELIX, S.B. (2002). Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion. Cardiovasc. Res., 53, 12 30. (Pubitemid 34020763)
124. SZALAY, L., KASZAKI, J., NAGY, S. BOROS, M. (2000). Endothelin-1 induces mucosal mast cell degranulation in the rat small intestine. Life Sci., 67, 1947 1958. (Pubitemid 30701564)
125. SZUKIEWICZ, D., MASLINSKA, D., SZUKIEWICZ, A. et al. (2001). The dose-dependent release of histamine from placental mast cells after administration of atrial natriuretic peptide. Inflamm. Res., 50, 59 60.
126. TAKAGI, G., KIUCHI, K., ENDO, T. et al. (2000). Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J. Cardiovasc. Pharmacol., 36, 22 30. (Pubitemid 30419118)
127. TAKATA, Y., HIRAYAMA, Y., KIYOMI, S. et al. (1996). The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion. Cardiovasc. Res., 32, 286 293. (Pubitemid 26246874)
128. TAYLOR, M.J. CLARK, C.L. (1994). Evidence for a novel source of relaxin: atrial cardiocytes. J. Endocrinol., 143, 5 8.
129. TRIGGIANI, M., GENOVESE, A., VIGORITO, C. MARONE, G. (1985). Histamine and the human heart. Int. Arch. Allergy. Appl. Immunol., 77, 174 176. (Pubitemid 15031447)
130. TSURUDA, T., KATO, J., HATAKEYAMA, K. et al. (2006). Adrenomedullin in mast cells of abdominal aortic aneurysm. Cardiovasc. Res., 70, 158 164.
131. VALSSON, F., LUNDIN, S., KIRNO, K. et al. (1999). Atrial natriuretic peptide attenuates pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease. Anesth. Analg., 88, 279 285. (Pubitemid 29070183)
132. WAINWRIGHT, C.L., MCCABE, C. KANE, K.A. (2005). Endothelin and the ischaemic heart. Curr. Vasc. Pharmacol., 3, 333 341. (Pubitemid 41264285)
133. WALSH, S.K., KANE, K.A. Wainwright, C.L. (2009). Mast cell degranulation a mechanism for the anti-arrhythmic effect of endothelin-1?. Br. J. Pharmacol., DOI :.
134. WALSH, S., KANE, K.A., MCCAIG, D.J. WAINWRIGHT, C.L. (2005). Endothelin-1 induces mast cell degranulation and increases tryptase level in the murine myocardium in vitro. J. Mol. Cell. Cardiol., 38, 856. Abstract 132).
135. WANG, X.F., SHAO, Y. CHEN, S.W. (2007). Amelioration of cardiac function in chronic myocardial infracted rats following administration of vector pcDNA3.1AM. Clin. Exp. Pharmacol. Physiol., 34, 861 865. (Pubitemid 47083972)
136. WEBER, T.P., RAUFHAKE, C., GROBE HARTLAGE, M.A. et al. (2002). Naloxone prevents increased atrial natriuretic peptide release during regional myocardial ischaemia and stunning in awake dogs. Br. J. Anaesth., 88, 87 93. (Pubitemid 34048567)
137. WOLFF, A.A. LEVI, R. (1986). Histamine and cardiac arrhythmias. Circ. Res., 58, 458 1 16. (Pubitemid 16165928)
138. YANG, X.P., LIU, Y.H., PETERSON, E. CARRETERO, O.A. (1997). Effect of neutral endopeptidase 24.11 inhibition on myocardial ischemia/reperfusion injury: the role of kinins. J. Cardiovasc. Pharmacol., 29, 250 256. (Pubitemid 27097728)
139. YANG, X.M., PHILIPP, S., DOWNEY, J.M. COHEN, M.V. (2006). Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res. Cardiol., 101, 311 318. (Pubitemid 43923387)
140. YIN, H., CHAO, L. CHAO, J. (2004). Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signalling. Hypertension, 43, 109 116. (Pubitemid 38031918)
141. YOSHIDA, H., INAGAKI, Y., YAMAKI, K. et al. (1996). Histamine release induced by human natriuretic peptide from rat peritoneal mast cells. Regul. Pept., 61, 45 49. (Pubitemid 26038194)
142. YOSHIDA, M., YOSHIDA, H., KITAICHI, K. et al. (2001). Adrenomedullin and proadrenomedullin N-terminal 20 peptide induce histamine release from rat peritoneal mast cell. Regul. Pept., 101, 163 168. (Pubitemid 32728383)
143. ZHANG, J., QI, Y.F., GENG, B. et al. (2005). Effect of relaxin on myocardial ischemia injury induced by isoproterenol. Peptides, 26, 1632 1639. (Pubitemid 41169758)
144. ZHANG, W.W., HASANIYA, N.W., PREMARATNE, S. MCNAMARA, J.J. (2008). Atrial natriuretic peptide protects against ischemia/reperfusion injury in rabbit hearts in vivo. Vasc. Endovascular. Surg., 42, 263 267. (Pubitemid 351852626)
145. ZUDAIRE, E., MARTINEZ, A., GARAYOA, M. et al. (2006). Adrenomeduliin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am. J. Pathol., 168, 280 291. (Pubitemid 43062580)